Cargando…
High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
BACKGROUND: Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver. Data on hepatic histopathological findings in COVID-19 is scarce. AIM: To characterize hepatic pathological findings in patients with COVID-19. METHODS: We conducted a systematic review with meta-analysis regist...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789052/ https://www.ncbi.nlm.nih.gov/pubmed/33505145 http://dx.doi.org/10.3748/wjg.v26.i48.7693 |
_version_ | 1783633155541958656 |
---|---|
author | Díaz, Luis Antonio Idalsoaga, Francisco Cannistra, Macarena Candia, Roberto Cabrera, Daniel Barrera, Francisco Soza, Alejandro Graham, Rondell Riquelme, Arnoldo Arrese, Marco Leise, Michael D Arab, Juan Pablo |
author_facet | Díaz, Luis Antonio Idalsoaga, Francisco Cannistra, Macarena Candia, Roberto Cabrera, Daniel Barrera, Francisco Soza, Alejandro Graham, Rondell Riquelme, Arnoldo Arrese, Marco Leise, Michael D Arab, Juan Pablo |
author_sort | Díaz, Luis Antonio |
collection | PubMed |
description | BACKGROUND: Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver. Data on hepatic histopathological findings in COVID-19 is scarce. AIM: To characterize hepatic pathological findings in patients with COVID-19. METHODS: We conducted a systematic review with meta-analysis registered on PROSPERO (CRD42020192813), following PRISMA guidelines. Eligible trials were those including patients of any age and COVID-19 diagnosis based on a molecular test. Histopathological reports from deceased COVID-19 patients undergoing autopsy or liver biopsy were reviewed. Articles including less than ten patients were excluded. Proportions were pooled using random-effects models. Q statistic and I(2) were used to assess heterogeneity and levels of evidence, respectively. RESULTS: We identified 18 studies from 7 countries; all were case reports and case series from autopsies. All the patients were over 15 years old, and 67.2% were male. We performed a meta-analysis of 5 studies, including 116 patients. Pooled prevalence estimates of liver histopathological findings were hepatic steatosis 55.1% [95% confidence interval (CI): 46.2-63.8], congestion of hepatic sinuses 34.7% (95%CI: 7.9-68.4), vascular thrombosis 29.4% (95%CI: 0.4-87.2), fibrosis 20.5% (95%CI: 0.6-57.9), Kupffer cell hyperplasia 13.5% (95%CI: 0.6-54.3), portal inflammation 13.2% (95%CI: 0.1-48.8), and lobular inflammation 11.6% (95%CI: 0.3-35.7). We also identified the presence of venous outflow obstruction, phlebosclerosis of the portal vein, herniated portal vein, periportal abnormal vessels, hemophagocytosis, and necrosis. CONCLUSION: We found a high prevalence of hepatic steatosis and vascular thrombosis as major histological liver features. Other frequent findings included portal and lobular inflammation and Kupffer cell hyperplasia or proliferation. Further studies are needed to establish the mechanisms and implications of these findings. |
format | Online Article Text |
id | pubmed-7789052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-77890522021-01-26 High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data Díaz, Luis Antonio Idalsoaga, Francisco Cannistra, Macarena Candia, Roberto Cabrera, Daniel Barrera, Francisco Soza, Alejandro Graham, Rondell Riquelme, Arnoldo Arrese, Marco Leise, Michael D Arab, Juan Pablo World J Gastroenterol Systematic Reviews BACKGROUND: Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver. Data on hepatic histopathological findings in COVID-19 is scarce. AIM: To characterize hepatic pathological findings in patients with COVID-19. METHODS: We conducted a systematic review with meta-analysis registered on PROSPERO (CRD42020192813), following PRISMA guidelines. Eligible trials were those including patients of any age and COVID-19 diagnosis based on a molecular test. Histopathological reports from deceased COVID-19 patients undergoing autopsy or liver biopsy were reviewed. Articles including less than ten patients were excluded. Proportions were pooled using random-effects models. Q statistic and I(2) were used to assess heterogeneity and levels of evidence, respectively. RESULTS: We identified 18 studies from 7 countries; all were case reports and case series from autopsies. All the patients were over 15 years old, and 67.2% were male. We performed a meta-analysis of 5 studies, including 116 patients. Pooled prevalence estimates of liver histopathological findings were hepatic steatosis 55.1% [95% confidence interval (CI): 46.2-63.8], congestion of hepatic sinuses 34.7% (95%CI: 7.9-68.4), vascular thrombosis 29.4% (95%CI: 0.4-87.2), fibrosis 20.5% (95%CI: 0.6-57.9), Kupffer cell hyperplasia 13.5% (95%CI: 0.6-54.3), portal inflammation 13.2% (95%CI: 0.1-48.8), and lobular inflammation 11.6% (95%CI: 0.3-35.7). We also identified the presence of venous outflow obstruction, phlebosclerosis of the portal vein, herniated portal vein, periportal abnormal vessels, hemophagocytosis, and necrosis. CONCLUSION: We found a high prevalence of hepatic steatosis and vascular thrombosis as major histological liver features. Other frequent findings included portal and lobular inflammation and Kupffer cell hyperplasia or proliferation. Further studies are needed to establish the mechanisms and implications of these findings. Baishideng Publishing Group Inc 2020-12-28 2020-12-28 /pmc/articles/PMC7789052/ /pubmed/33505145 http://dx.doi.org/10.3748/wjg.v26.i48.7693 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Systematic Reviews Díaz, Luis Antonio Idalsoaga, Francisco Cannistra, Macarena Candia, Roberto Cabrera, Daniel Barrera, Francisco Soza, Alejandro Graham, Rondell Riquelme, Arnoldo Arrese, Marco Leise, Michael D Arab, Juan Pablo High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data |
title | High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data |
title_full | High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data |
title_fullStr | High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data |
title_full_unstemmed | High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data |
title_short | High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data |
title_sort | high prevalence of hepatic steatosis and vascular thrombosis in covid-19: a systematic review and meta-analysis of autopsy data |
topic | Systematic Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789052/ https://www.ncbi.nlm.nih.gov/pubmed/33505145 http://dx.doi.org/10.3748/wjg.v26.i48.7693 |
work_keys_str_mv | AT diazluisantonio highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT idalsoagafrancisco highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT cannistramacarena highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT candiaroberto highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT cabreradaniel highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT barrerafrancisco highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT sozaalejandro highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT grahamrondell highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT riquelmearnoldo highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT arresemarco highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT leisemichaeld highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata AT arabjuanpablo highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata |